Ferric Derisomaltose (Iron Isomaltoside) Versus Iron Sucrose for Treatment of Iron Deficiency in Pregnancy

Inclusion Criteria: * 18 years of age and over * Pregnancy with Gestational age ≥13 weeks * Iron deficiency anemia defined as: * Hemoglobin less than or equal to 110g/L and * Serum ferritin less than 30ng/mL or * Iron Saturation (Iron/TIBC) less than 20% * Willing to participate and attend all planned follow up visits * Willing to sign informed consent form * Willing to attend appointments for iron infusion and follow up visits * Willing to attend all planned bloodwork appointments Exclusion Criteria: * Pregnancy GA less than 13 weeks * History of anemia caused by thalassemia or other haematologic disorder other than iron deficiency anemia , * Known serious hypersensitivity to other parental iron products * Iron overload or disturbances in utilization of iron (i.e, haemochromatosis and haemosiderosis) * Decompensated liver cirrhosis or active hepatitis * History of multiple allergies * Active acute or chronic infections * Treated with IV iron products or blood transfusion within 4 weeks prior to inclusion * Current participation in any other interventional trial * Multiple gestation pregnancy * Significant comorbidities (asthma requiring daily therapy or other lung diseases) * Heart disease * Kidney disease * Rheumatologic disease * Cancer * Known hypersensitivity to iron sucrose or any excipients * Known hypersensitivity to iron isomaltoside or any excipients.